Market Research Life Sciences Market Research Diagnostics Market Research In Vitro Diagnostics Market Research Clinical Chemistry Market Research

Antimicrobial Susceptibility Testing Market by Product Type (Automated Products, Consumables, Manual Products), Method (Agar Dilution, Disks Diffusion, ETEST), Type, Application, End-User - Global Forecast 2023-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,949 181 Pages 360iResearch October, 2023 IRE18311821
Best Price Guarantee
Price from $4,949
Length 181 Pages
Publisher 360iResearch
Published Date October, 2023
SKU IRE18311821

Antimicrobial Susceptibility Testing Market by Product Type (Automated Products, Consumables, Manual Products), Method (Agar Dilution, Disks Diffusion, ETEST), Type, Application, End-User - Global Forecast 2023-2030


The Antimicrobial Susceptibility Testing Market is projected to reach USD 5.67 billion by 2030 from USD 3.61 billion in 2022, at a CAGR of 5.80% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Antimicrobial Susceptibility Testing Market.
  • Based on Product Type, market is studied across Automated Products, Consumables, and Manual Products. The Manual Products is further studied across Minimum Inhibitory Concentration (MIC) Strips, Susceptibility Discs, and Susceptibility Plates. The Automated Products commanded largest market share of 39.83% in 2022, followed by Consumables.
  • Based on Method, market is studied across Agar Dilution, Disks Diffusion, ETEST, Genotyping Methods, and Rapid Automation Method. The ETEST commanded largest market share of 29.60% in 2022, followed by Disks Diffusion.
  • Based on Type, market is studied across Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, and Antiparasitic Susceptibility Testing. The Antibacterial Susceptibility Testing commanded largest market share of 57.92% in 2022, followed by Antifungal Susceptibility Testing.
  • Based on Application, market is studied across Clinical Diagnostics, Drug Discovery & Development, and Epidemiology. The Clinical Diagnostics commanded largest market share of 48.92% in 2022, followed by Drug Discovery & Development.
  • Based on End-User, market is studied across Contract Research Organizations, Hospital & Diagnostic Centers, Pharmaceutical & Biotechnology, and Research & Academic Institutes. The Pharmaceutical & Biotechnology commanded largest market share of 36.54% in 2022, followed by Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.52% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Antimicrobial Susceptibility Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Antimicrobial Susceptibility Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Antimicrobial Susceptibility Testing Market, highlighting leading vendors and their innovative profiles. These include Accelerate Diagnostics, Inc., Alifax S.r.l., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BIOANALYSE Tıbbi Malz. San. ve Tic. Ltd. Sti., BioMérieux SA, Biosafe Ltd., Bruker Corporation, Creative Diagnostics, Danaher Corporation, ELITech Group SAS, Erba Lachema s.r.o., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genefluidics, Inc., Himedia Laboratories Private Limited, INTEGRA Biosciences AG, Laboratorios Conda, S.A., Launch Diagnostics Limited, Leading Biology, Inc., Liofilchem S.r.l., Mast Group Ltd., MP Biomedicals, LLC, Pfizer Inc., Qiagen N.V., QuantaMatrix Inc., Rapid Test Methods Ltd., Resistell AG, Synoptics Group, Thermo Fisher Scientific Inc., and Zhuhai DL Biotech Co., Ltd..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Antimicrobial Susceptibility Testing Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Antimicrobial Susceptibility Testing Market?
  3. What is the competitive strategic window for identifying opportunities in the Antimicrobial Susceptibility Testing Market?
  4. What are the latest technology trends and regulatory frameworks in the Antimicrobial Susceptibility Testing Market?
  5. What is the market share of the leading vendors in the Antimicrobial Susceptibility Testing Market?
  6. Which modes and strategic moves are suitable for entering the Antimicrobial Susceptibility Testing Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Antimicrobial Susceptibility Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Importance of antimicrobial susceptibility testing in medical decision-making
5.1.1.2. Favorable government initiatives aiming to combat and prevent infectious diseases
5.1.2. Restraints
5.1.2.1. High cost of antimicrobial susceptibility kits and lack of skilled professionals
5.1.3. Opportunities
5.1.3.1. Ongoing research on nanoparticles-based antimicrobial susceptibility testing
5.1.3.2. Introduction of new genomic identification methods and launch of antimicrobial susceptibility test kits
5.1.4. Challenges
5.1.4.1. Incidence of product recalls and strict regulations regarding antimicrobial susceptibility testing commercialization
5.2. Market Segmentation Analysis
5.2.1. Product Type: Advancement in the automated tools and consumables for early diagnosing and treatment of the infectious diseases
5.2.2. Method: Development of qualitative AST techniques with increased accuracy of the tests
5.2.3. Type: Significant advancements in antifungal susceptibility testing due to heightened awareness of invasive fungal infections
5.2.4. Application: Rapid and extreme utilization of the AST in clinical diagnostics and drug discovery and development
5.2.5. End-User: Extensive use of AST in hospitals and diagnostic laboratories
5.3. Market Trend Analysis
5.3.1. Government programs and significant research activities to develop antimicrobial susceptibility tests in the Americas.
5.3.2. Emphasis on the antibiotic susceptibility testing research and development programmes to treat and diagnose highly prevalent communicable diseases in APAC
5.3.3. Significant funding for antibiotic susceptibility testing and support from regulatory agencies in the EMEA region.
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Antimicrobial Susceptibility Testing Market, by Product Type
6.1. Introduction
6.2. Automated Products
6.3. Consumables
6.4. Manual Products
6.5.1. Minimum Inhibitory Concentration (MIC) Strips
6.5.2. Susceptibility Discs
6.5.3. Susceptibility Plates
7. Antimicrobial Susceptibility Testing Market, by Method
7.1. Introduction
7.2. Agar Dilution
7.3. Disks Diffusion
7.4. ETEST
7.5. Genotyping Methods
7.6. Rapid Automation Method
8. Antimicrobial Susceptibility Testing Market, by Type
8.1. Introduction
8.2. Antibacterial Susceptibility Testing
8.3. Antifungal Susceptibility Testing
8.4. Antiparasitic Susceptibility Testing
9. Antimicrobial Susceptibility Testing Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.3. Drug Discovery & Development
9.4. Epidemiology
10. Antimicrobial Susceptibility Testing Market, by End-User
10.1. Introduction
10.2. Contract Research Organizations
10.3. Hospital & Diagnostic Centers
10.4. Pharmaceutical & Biotechnology
10.5. Research & Academic Institutes
11. Americas Antimicrobial Susceptibility Testing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Antimicrobial Susceptibility Testing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Antimicrobial Susceptibility Testing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Bio-Rad Acquires Curiosity Diagnostics
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. JMI Laboratories and bioMérieux Enter Antimicrobial Resistance Diagnostics Partnership
14.3.2.2. FASTinov Collaborates With Beckman Coulter Life Sciences To Bring Ultra-Rapid 2h-AST Disruptive Technology To Clinical Microbiology Laboratories
14.3.2.3. BD Enters Commercial Collaboration With Accelerate Diagnostics
14.3.3. New Product Launch & Enhancement
14.3.3.1. Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
14.3.3.2. Sysmex Launches World's First Point-of-Care Testing System in Europe to Detect Antimicrobial Susceptibility in Just 30 Minutes
14.3.4. Investment & Funding
14.3.4.1. Strathclyde spin-out Microplate dx secures GBP 2.5 million in funding
14.3.4.2. Pattern Bioscience Secures USD 28.7 Million in Series C Financing
14.3.4.3. Resistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing
14.3.4.4. Avails Medical, A Developer 0f Automated and Fully Electrical Antibiotic Susceptibility Testing (East) has Announced the Transition to The Next Phase of Its Carb-X Grant.
14.3.5. Award, Recognition, & Expansion
14.3.5.1. Gradientech Welcomes Investment From Commercial Partner
14.3.5.2. bioMérieux's Submits Vitek Reveal to FDA for Clearance
14.3.5.3. Selux Diagnostics Secures FDA Approval For Its Rapid Antibiotic Susceptibility Test
14.3.5.4. FDA clears rapid antibiotic susceptibility test
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Accelerate Diagnostics, Inc.
15.1.2. Alifax S.r.l.
15.1.3. Becton, Dickinson and Company
15.1.4. Bio-Rad Laboratories, Inc.
15.1.5. BIOANALYSE Tıbbi Malz. San. ve Tic. Ltd. Sti.
15.1.6. BioMérieux SA
15.1.7. Biosafe Ltd.
15.1.8. Bruker Corporation
15.1.9. Creative Diagnostics
15.1.10. Danaher Corporation
15.1.11. ELITech Group SAS
15.1.12. Erba Lachema s.r.o.
15.1.13. Eurofins Scientific SE
15.1.14. F. Hoffmann-La Roche AG
15.1.15. Genefluidics, Inc.
15.1.16. Himedia Laboratories Private Limited
15.1.17. INTEGRA Biosciences AG
15.1.18. Laboratorios Conda, S.A.
15.1.19. Launch Diagnostics Limited
15.1.20. Leading Biology, Inc.
15.1.21. Liofilchem S.r.l.
15.1.22. Mast Group Ltd.
15.1.23. MP Biomedicals, LLC
15.1.24. Pfizer Inc.
15.1.25. Qiagen N.V.
15.1.26. QuantaMatrix Inc.
15.1.27. Rapid Test Methods Ltd.
15.1.28. Resistell AG
15.1.29. Synoptics Group
15.1.30. Thermo Fisher Scientific Inc.
15.1.31. Zhuhai DL Biotech Co., Ltd.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing

$4,949
$5,949
$6,949
$8,949

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings